A three-member committee has been set up to investigate the issue of substandard antibiotic Maximizin-625 supplied by Life Line Pharamaco Surgical Ltd, Health Minister Shabir Ahmed Khan said in a statement.
He also said the Controller Drug Stores, Kashmir has been placed under suspension and attached with the Directorate of Health Services, Jammu pending enquiry.
He said a committee comprising Special Secretary, Financial Advisor Health and Medical Education Department and Controller Drug and Food Organisation has been constituted to enquire into the matter thoroughly and submit its report within 15 days for taking necessary action against the accused firm.
The Chairman Central Purchase Committee has been directed to initiate the process of black listing the firm, he said.
He said the medicine (Maximizin-625) was lifted from Provincial Medical Store, Barzulla on February 2 and the sample was sent to Drug Testing Laboratory, Srinagar for analysis where it was found to be sub-standard.
Earlier, Medical Education Minister Taj Mohideen told reporters, "A criminal case has been registered against the company for the supply of fake amoxicillin capsules, endangering the lives of thousands of patients in the state."
"It is a heinous crime. I am ashamed of officers and others who have passed these drugs before testing them", he said.
The Pharma company had supplied 50,000 Maximizen capsules worth Rs 10 lakh out of which 80 per cent were consumed, he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
